Fluorescein Sodium Injection Shortage

• • Akorn ceased operations in February 2023.
  • Alcon has Fluorescite 10% injection available.
  • Nexus launched fluorescein 10% injection in late-October 2023. The company plans to launch the 25% fluorescein 2 mL vials in March 2024.
  • Long Grove Pharmaceuticals acquired AK-Fluor from Akorn. Before Long Grove acquired the drug Akorn ceased manufacturing. Long Grove is coordinating with FDA to distribute the inventory Akorn had made prior to their closure. More information can be found at: https://www.fda.gov/media/173588/download.

• • AK-Fluor laryngeal solution for injection, Long Grove Pharmaceuticals, 25%, 2 mL vial, 12 count, NDC 17478-0250-20
  • AK-Fluor solution for injection, Long Grove Pharmaceuticals, 10%, 5 mL vial, 12 count, NDC 17478-0253-10
  • Fluorescite solution for injection, Alcon Labs, 10%, 5 mL vial, 12 count, NDC 00065-0092-65
  • Fluorescein sodium solution for injection, Nexus Pharmaceuticals, 10%, 5 mL vial, 12 count, NDC 14789-0122-05

Estimated Resupply Dates

• • All marketed presentations are available.

Alternative Agents & Management

• • Indigotindisulfonate sodium (Bludigo) is labeled for use as a visualization aid in cytoscopic assessment of the integrity of the ureters in adults following urological and gynecological open, robotic, or endoscopic surgical procedures.

References

• 1. Lexi-Drugs Online. Hudson, OH: Lexi-Comp, Inc.; 2023. Accessed June 19, 2023.